Time to Treatment and Three-Year Mortality After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction—a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) Substudy - 05/08/11
, Peter Haubjerg Nielsen, MS a, †, Martin Busk, MD a, Leif Spange Mortensen, MSc b, Steen Dalby Kristensen, MD, DMSc a, Torsten Toftegaard Nielsen, MD, DMSc, DMSc a, Henning Rud Andersen, MD, DMSc aDANAMI-2 Investigators
Corresponding author: Tel: (+45) 8949-5566; fax: (+45) 8949-6025Résumé |
In patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (pPCI), early reperfusion is believed to improve left ventricular systolic function and reduce mortality; however, long-term (>1 year) data are sparse. In the DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) study, 686 patients with ST-segment elevation myocardial infarction were treated with pPCI. Long-term mortality was obtained during 3 years of follow-up. We classified the patients according to the symptom-to-balloon time (<3, 3 to 5, and ≥5 hours). The groups were compared using a Cox proportional hazards regression model adjusted for confounding factors. The left ventricular systolic ejection fraction was estimated by echocardiography before discharge. Coronary flow was evaluated using the Thrombolysis In Myocardial Infarction score. Mortality did not differ between the 2 earliest symptom-to-balloon groups, and they were therefore combined into 1 group in the analysis of survival. Mortality was significantly increased for patients with a symptom-to-balloon time ≥5 hours (hazard ratio 2.36, 95% confidence interval 1.51 to 3.67, p <0.001), a difference that remained significant after controlling for confounding factors (adjusted hazard ratio 2.44, 95% confidence interval 1.31 to 4.54, p = 0.007). The symptom-to-balloon time was inversely associated with a left ventricular systolic ejection fraction of ≤40% (19.7% vs 22.8% vs 33.1%, p = 0.036), with the latter a major predictor of 3-year mortality in this cohort (hazard ratio 6.02, 95% confidence interval 3.68 to 9.85, p <0.001). A shorter symptom-to-balloon time was associated with greater rates of Thrombolysis In Myocardial Infarction 3 flow after pPCI (86.5% vs 80.9% vs 75.7%, p = 0.002). In conclusion, a shorter symptom-to-balloon time was associated with improved coronary flow, an increased likelihood of subsequent left ventricular systolic ejection fraction >40%, and greater 3-year survival in patients with ST-segment elevation myocardial infarction treated with pPCI.
Le texte complet de cet article est disponible en PDF.Plan
Vol 105 - N° 11
P. 1528-1534 - juin 2010 Retour au numéro
Article précédent
- Intracoronary Compared to Intravenous Abciximab and High-Dose Bolus Compared to Standard Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Transradial Primary Percutaneous Coronary Intervention: a Two-by-Two Factorial Placebo-Controlled Randomized Study
- Olivier F. Bertrand, Josep Rodés-Cabau, Éric Larose, Stéphane Rinfret, Valérie Gaudreault, Guy Proulx, Gérald Barbeau, Jean-Pierre Déry, Onil Gleeton, Can Manh-Nguyen, Bernard Noël, Louis Roy, Olivier Costerousse, Robert De Larochellière, EArly Discharge after Transradial Stenting of CoronarY Arteries in Acute Myocardial Infarction (EASY-MI) Study Investigators
- Results of Interventional Treatment of Stress Positive Coronary Artery Disease
- Umar Adamu, Daniela Knollmann, Wael Alrawashdeh, Bader Almutairi, Verena Deserno, Eduard Kleinhans, Wolfgang Schäfer, Rainer Hoffmann
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?